Patents Assigned to Somerset Therapuetics, LLC
  • Patent number: 11478492
    Abstract: Disclosed herein are compositions comprising tobramycin or a tobramycin derivative that exhibit improvements in permeation of corneal cells, retention in corneal cells, or both. Such compositions can comprise tobramycin or tobramycin derivative(s) complexed to an agent which facilitates improved permeation of corneal cells, retention in corneal cells, or both. The invention also relates to a process of preparing such compositions.
    Type: Grant
    Filed: November 1, 2021
    Date of Patent: October 25, 2022
    Assignee: Somerset Therapuetics, LLC
    Inventors: Mandar V. Shah, Veerappan Subramanian, Ilango Subramanian, Ojas Prakashbhai Doshi